<DOC>
	<DOCNO>NCT02877771</DOCNO>
	<brief_summary>The goal study assess functionality integrate predictive low glucose suspend system design minimize incidence duration hypoglycemia suspend insulin delivery hypoglycemia project .</brief_summary>
	<brief_title>Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study</brief_title>
	<detailed_description>This protocol design test functionality predictive low glucose suspend system supervise condition basal insulin rate manually increase system generate suspension occur . The study collect data use plan pivotal study , study data intend used support Premarket Approval ( PMA ) application .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diagnosis type 1 diabetes require insulin therapy least 12 month Insulin pump therapy least 6 month Age â‰¥18.0 year Subject demonstrate stable insulin regimen include basal rate , insulin sensitivity factor insulin : carbohydrate ratio least 3 month Pregnant ( female subject must negative urine serum pregnancy screen test ) Severe hypoglycemia result seizure loss consciousness month prior enrollment Diabetic ketoacidosis month prior enrollment A current condition would prevent use CGM sensor insulin pump , judgment investigator contraindication study participation Use acetaminophen study participation Current use medication intend low glucose insulin include naturaceuticals , oral noninsulin injectable medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>